期刊文献+

腹盆部Castleman病的诊治分析 被引量:3

Diagnosis and treatment of abdominal and pelvic Castleman's disease
原文传递
导出
摘要 目的探讨腹盆部Castleman病的临床特点和治疗方法。方法回顾性分析2007年1月至2017年10月郑州大学第一附属医院经病理确诊的51例腹盆部Castleman病患者的临床病理资料。根据临床分型分为两组,局灶型Castleman病组(42例)和多中心型Castleman病组(9例)。结果局灶型42例患者中32例无症状(76%),其他伴腹部、腰背部疼痛、腹胀。病理以透明血管型为主(93%),41例通过手术治疗治愈。多中心型表现为全身多发浅表及深部淋巴结肿大,伴贫血、发热、体重减轻、呼吸困难。实验室检查可出现血清C反应蛋白升高、低蛋白血症、球蛋白增多、白细胞增多等。病理以浆细胞型为主(56%)。3例病情无进展,6例手术后部分缓解。结论腹盆部Castleman病需要病理检查确诊。局灶型临床症状轻微,手术治疗预后好;多中心型临床症状复杂,需要综合治疗,预后较差。 Objective To explore the diagnosis and treatment of Castleman's disease (CD) of the abdomen and pelvis.Methods The clinical data of 51 cases of abdomen and pelvis CD were analyzed retrospectively from Jan 2007 to Oct 2017 in the First Affiliated Hospital of Zhengzhou University.Patients were divided into two groups according to the different clinical classifications : Localized CD (n=42) and Multicentric CD (n=9).Results 32 cases of LCD were asymptomatic (76%), others accompanied by abdominal or waist pain, abdominal distention.The main pathological type was hyaline vascular (93%), which can be cured by surgical treatment (41/42).MCD always accompanied by multiple superficial and deep lymph node enlargement in the whole body.Most of them suffered from anemia, fever, weight loss and dyspnea.CRP increased, hypoproteinemia, globulin increased, neutropenia were found.The main pathological type was plasma cell type (56%).There were no progress in 3 cases, and 6 cases were on remission after operation.Conclusion The diagnosis of abdomen and pelvis CD depends on pathological examination.LCD clinical symptoms are mild and good prognosis after surgery.However, MCD clinical manifestations are complex, and relatively poor prognosis after comprehensive treatment.
作者 薛建锋 郝乔 宋盛平 杨理想 时洋洋 Xue Jianfeng;Hao Qiao;Song Shengping;Yang Lixiang;Shi Yangyang(Department of Hepatobiliary Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China)
出处 《中华普通外科杂志》 CSCD 北大核心 2019年第5期393-396,共4页 Chinese Journal of General Surgery
关键词 巨淋巴结增生 病理学 临床 Giant lymph node hyperplasia Pathology, clinical
  • 相关文献

参考文献7

二级参考文献51

  • 1张晖,俞清,杜红,丁红,王文平,徐智章.Castleman病的影像学诊断[J].中华超声影像学杂志,2005,14(6):441-444. 被引量:24
  • 2Castleman B, Iverson L, Menendex VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9 : 822-830.
  • 3Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 1972, 29 : 670-683.
  • 4Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol, 1988, 5: 346-364.
  • 5Bacon CM, Miller RF, Noursadeghi M, et al. Pathology of bone marrow in human herpes virus-8 ( HHV8 ) -associated multicentric Castleman disease. Br J Haematol, 2004, 127: 585-591.
  • 6Nishimoto N, Terao K, Mima T, et al. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-5)and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease. Blood, 2008, 112: 3959-3964.
  • 7Peterson BA, Frizzera G. Muhicentric Castleman's disease. Semin Oncol, 1993, 20: 636-647.
  • 8Dupin N, Diss TL, Kellarn P, et al. HHV-8 is associated with a plasmablastie variant of Castleman disease that is linked to HHV-8- positive plasmablastic lymphoma. Blood, 2000, 95 : 1406-1412.
  • 9Bower M, Veraitch O, Szydlo R, et al. Cytokine changes during rituximab therapy in HIV-assoeiated muhieentrie Castleman disease. Blood, 2009, 113 : 4521-4524.
  • 10Katsume A, Saito H, Yamada Y, et al. Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenie mice. Cytokine, 2002, 20 : 304-311.

共引文献28

同被引文献13

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部